ProQR Therapeutics N.V. PRQR
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- -48.51%
- 1 year
- -49.51%
Ownership
- Institutions 25.0%
- Insiders 14.5%
- Public and other holders 60.5%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Privium Fund Management B.V. | 6.90% | 5,632,388 | 15.04M | Sep 29, 2024 |
| Adage Capital Partners GP L.L.C. | 4.44% | 3,625,467 | 9.68M | Sep 29, 2024 |
| EcoR1 Capital, LLC | 2.25% | 1,835,991 | 4.90M | Sep 29, 2024 |
| M28 Capital Management LP | 1.25% | 1,019,498 | 2.72M | Sep 29, 2024 |
| DAFNA Capital Management, LLC | 1.11% | 905,582 | 2.42M | Sep 29, 2024 |
| Ghost Tree Capital, LLC | 1.09% | 887,700 | 2.37M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Delaware Group Equity Fds IV-Delaware Healthcare Fund | 0.76% | 620,000 | 1.66M | Sep 29, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.06% | 46,671 | 124.61K | Oct 30, 2024 |
| Northern Small Cap Core Fund | 0.01% | 5,007 | 13.37K | Sep 29, 2024 |
| Voya International Small Cap Fund | 0.01% | 8,436 | 22.52K | Sep 29, 2024 |
| Avantis International Small Cap Equity ETF | 0.00% | 388 | 1.03K | Sep 29, 2024 |
| Blackstone Alternative Multi-Strategy Fund | 0.00% | 3,300 | 8.81K | Sep 29, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs PRQR, and what each was last paid
Daniel Anton de Boer, Founder, CEO & Executive DirectorAverage age 50
| Name | Title | Pay | Age |
|---|---|---|---|
| Daniel Anton de Boer | Founder, CEO & Executive Director | €1.05M | 43 |
| Gerard Platenburg | Co-Founder, Chief Scientific Officer & Executive Director | €645K | 62 |
| Dennis Hom | Chief Financial Officer | — | 51 |
| Golnar Karimian | Head of Hepatology | — | — |
| Christopher Hart | Chief Data & AI Officer | — | — |
| Cristina Lopez Lopez | Chief Medical Officer | — | 50 |
| Sandra van der Kolk | Junior Financial Controller | — | — |
| Sarah Cue Kiely | Vice President of Investor Relations & Corporate Communications | — | — |
| Sheila Sponselee | Chief People & Operations Officer | — | 42 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
No insider holdings on record
